Study sharpens focus on Glaxo's heart drug hope (Reuters)

Reuters - A scientific study provided support on Friday for a way of fighting heart disease being pioneered by GlaxoSmithKline, likely to boost interest in drugs that target an enzyme involved in clogging arteries.